About Patrick Ryan
Patrick Ryan has invested in stocks and traded options for more than a decade. He specializes in growth stocks, with a particular focus on those in the technology and entertainment sectors. Patrick began writing for StockNews.com in 2019. His mission is to pinpoint growth stocks trading at attractive prices. This requires a focus on the fundamentals including in-depth qualitative and quantitative analysis. Patrick often abides by a contrarian market strategy as he analyzes investment opportunities with irreverence for conventional logic. This often leads to finding hidden gems with tremendous long term upside potential.
Recent Articles By Patrick Ryan
Down 7% in 2021, Will Nike Stock Rebound?
Nike (NKE) has been an outperformer for most of the last two decades. Thus, it's noteworthy that it's down 7% this year, while the S&P 500 is up 12% YTD. Patrick Ryan explains why you should buy the dip.
Is Brightcove a Winning Software Stock?
As more and more companies migrate their businesses to the cloud, this cutting edge technology is here to stay. The company's that provide cloud products and services should see their stock's rise over the long-term, but not every stock is a buy right now. In this article, Patrick Ryan covers a lesser known cloud, Brightcove (BCOV), with bright prospects.
3 Recently Downgraded Stocks to Avoid This Month
Greenlane Holdings (GNLN), Integrated Media Technology Limited (IMTE), and Summit Hotel Properties (INN) are 3 stocks recently downgraded by the POWR Ratings. Patrick Ryan explains why investors should avoid these stocks.
Grab These Upgraded Stocks for May
If you're looking for stocks that have a higher potential for outperformance in the months ahead, our POWR Ratings service has you covered. Stocks that were recently upgraded to Strong Buys such as Dover (DOV), Johnson & Johnson (JNJ), and Movado Group (MOV) are heading in the right direction. Read more to learn why these stocks are primed for strong performance.
4 Lesser-Known Biotech Stocks to Consider Adding to Your Portfolio
The COVID-19 pandemic brought a renewed interest to biotech firms, with many searching for treatments and vaccines. This led to strong returns for many top biotech stocks. But there are smaller, lesser know companies that are also poised for strong returns such as Vanda Pharmaceuticals (VNDA), Sino Biopharmaceutical (SBHMY), Otsuka Holdings (OTSKY), and Xoma (XOMA).
Clean Energy Fuels: Buy, Sell, and Hold?
Clean Energy Fuels (CLNE) is down nearly 50% since early February. Should investors buy the dip? Or is it the start of a bear market for the stock? Patrick Ryan breaks it down below.
Is Darden Restaurants a Buy?
Restaurants companies like Darden Restaurants (DRI) struggled during the pandemic, but the stock has shown bullish momentum over the past couple months. As the economy continues to open up, more and more people are heading back to restaurants. But is the stock a buy at its current price? Read more to find out.
Tyson vs. Sanderson Farms: Which Food Stock is a Better Buy?
Tyson Foods (TSN) and Sanderson Farms (SAFM) are two of the leading food stocks. They should benefit from rising food prices and increased consumer spending. Patrick Ryan breaks down which is the better buy.
Mohawk Industries Remains a Buy Following 42% YTD Gain
Mohawk Industries (MHK) is a winner from the improving housing market and looming infrastructure bill. The stock is up 42% YTD. Patrick Ryan explains why he believes it remains a buy.